Blackrock specialists in their annual review of key trends in the financial markets are looking for answers to the questions that 2022 has asked.
The paper analyses the main development trends of the pharmaceutical market in the BRICS countries. The main challenges and relevant tasks in the pharmaceutical industry of the BRICS countries are defined. Correspondent solutions providing maximum satisfaction of all involved parties, aimed at further successful development of the BRICS pharmaceutical market are proposed. The forecast for the pharmaceutical industry of the BRICS counties development is presented.
DSM Group has published its annual report where it describes the current state of the pharmaceutical market, reviews main legislative initiatives in the sector, and presents national pharmaceutical ratings for 2017.
Deloitte CIS Research Centre has produced an analytical report about the situation on the Russian pharmaceutical market in 2017 and its prospects for growth in 2018.
Kevin Ali, President of MSD International, shares his vision of the future of healthcare: why vaccination is needed, how to win the race with bacteria, and whether it is possible to invent a universal medicine to fight cancer.
Russia’s success in the future depends largely on the dynamics of human capital. Health and education are two main human capital issues. Leadership in the global economy will increasingly be determined by the country’s competitiveness in the global markets of educational and medical technologies and services. In this connection, in the industry whose orientation is limited primarily to the detection and treatment of diseases, healthcare should become an integrated interdisciplinary system that can not only more effectively solve medical and social problems, but also be one of the main drivers of the growth of the Russian economy.
